Lucira Health, Inc.
CIK 0001652724
Revenue (TTM)
$165.99M
+34,492.9% YoY
Q3 Nov 2022
Net Income (TTM)
−$162.94M
−73.6% YoY
Q3 Nov 2022
EPS Diluted (TTM)
−$4.09
Q3 Nov 2022
Gross Margin
-32.0%
Q3 Nov 2022
Operating Margin
-97.3%
Q3 Nov 2022
Net Margin
-98.2%
Q3 Nov 2022
Free Cash Flow (TTM)
−$116.27M
Q3 Nov 2022
Cash
$39.77M
Q3 Nov 2022
Total Debt
$29.41M
Q3 Nov 2022
Shares Outstanding
40.6M sh
Q3 Nov 2022